Has success spoiled hairy cell leukemia research? Key questions go unanswered, despite big gains

J Natl Cancer Inst. 2009 Mar 18;101(6):370-3. doi: 10.1093/jnci/djp051. Epub 2009 Mar 10.
No abstract available

Publication types

  • Historical Article
  • News

MeSH terms

  • Animals
  • Antibodies, Monoclonal / pharmacology*
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / history
  • Antineoplastic Agents / pharmacology*
  • Antineoplastic Agents / therapeutic use
  • Biomedical Research / history
  • Biomedical Research / trends*
  • Bone Marrow / drug effects
  • Cell Proliferation / drug effects
  • Cladribine / pharmacology
  • History, 20th Century
  • History, 21st Century
  • Humans
  • Immunosuppressive Agents / pharmacology
  • Interferons / pharmacology
  • Leukemia, Hairy Cell* / drug therapy
  • Leukemia, Hairy Cell* / history
  • Leukemia, Hairy Cell* / immunology
  • Leukemia, Hairy Cell* / mortality
  • Leukemia, Hairy Cell* / pathology
  • Leukocyte Count
  • Leukocytes / drug effects*
  • Nucleosides / adverse effects*
  • Nucleosides / pharmacology*
  • Pentostatin / pharmacology
  • Rituximab
  • Workforce

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents
  • Immunosuppressive Agents
  • Nucleosides
  • Pentostatin
  • Cladribine
  • Rituximab
  • Interferons